These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15761945)

  • 1. The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers.
    Srichana T; Suedee R; Muanpanarai D; Tanmanee N
    J Pharm Sci; 2005 Jan; 94(1):220-30. PubMed ID: 15761945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation development and in vivo evaluation of a new dry powder formulation of albuterol sulphate in beagle dogs.
    Kuehl PJ; Barrett EG; McDonald JD; Rudolph K; Vodak D; Dobry D; Lyon D
    Pharm Res; 2010 May; 27(5):894-904. PubMed ID: 20232119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisation.
    Srichana T; Suedee R; Tanmanee N; Muanpanarai D; Marriott C
    Pulm Pharmacol Ther; 2007; 20(1):36-45. PubMed ID: 16325440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
    Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
    Harrison LI; Novak CC; Needham MJ; Ratner P
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
    Chege JK; Chrystyn H
    Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.
    Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
    Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products.
    Daley-Yates PT; Parkins DA; Thomas MJ; Gillett B; House KW; Ortega HG
    Clin Ther; 2009 Feb; 31(2):370-85. PubMed ID: 19302910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers.
    Anderson PJ; Zhou X; Breen P; Gann L; Logsdon TW; Compadre CM; Hiller FC
    J Pharm Sci; 1998 Jul; 87(7):841-4. PubMed ID: 9649352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence of pharmacokinetic characteristics and bronchodilating effect between two combined formulations of nedocromil sodium and salbutamol: MDI and nebulizer solution.
    Reggio S; Bustacchini S; Pistelli R; Valente S
    Int J Clin Pharmacol Res; 1996; 16(1):19-27. PubMed ID: 9001926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of innovator and generic salbutamol inhalers: a double-blind randomized study of efficacy and tolerance.
    Pinto Pereira LM; Clement YN; Pinto Pereira SM
    Int J Clin Pharmacol Res; 2002; 22(3-4):73-80. PubMed ID: 12837043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients.
    Laurikainen K; Silvasti M; Calderon P; Lins R; Rosillon D
    Arzneimittelforschung; 1997 Jan; 47(1):44-6. PubMed ID: 9037443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
    Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
    Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
    Ahrens RC; Hendeles L; Clarke WR; Dockhorn RJ; Hill MR; Vaughan LM; Lux C; Han SH
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.